Site icon OncologyTube

CAR-Ts: Next Generation Products and Strategies? Upfront, High Risk?

Earn CME: https://www.naccme.com/program/19-lm-06 In this webcast from the ‘New Immunological Approaches to Myeloma: CAR T-Cell Therapy and Other Novel Strategies’ symposium during the 2019 Lymphoma & Myeloma conference in New York, Dr. Adam D. Cohen discusses next-generation CAR-T produces and strategies. © 2019 Imedex, an HMP Company

Exit mobile version